TGF-β1 polymorphisms and risk of myocardial infarction and stroke: The Rotterdam study

Stroke

Volumn 37, Issue 11, 2006, Pages 2667-2671

  Sie, Mark P S ^a   Uitterlinden, André G ^a   Bos, Michiel J ^a   Arp, Pascal P ^a   Breteler, Monique M B ^a   Koudstaal, Peter J ^a   Pols, Huibert A P ^a   Hofman, Albert ^a   Van Duijn, Cornelia M ^a   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Myocardial infarction; Polymorphisms; Stroke; Transforming growth factor

Indexed keywords

ADENINE; ARGININE; CYTOSINE; GUANINE; ISOLEUCINE; LEUCINE; PROLINE; THREONINE; THYMINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ALLELE; ARTICLE; CODON; CONFIDENCE INTERVAL; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STROKE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ALLELES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33750964898     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000244779.30070.1a     Document Type: Article

References (29)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419-S420.
3. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990;6:597-641.
4. Grainger DJ, Metcalfe JC. A pivotal role for TGF-β in atherogenesis? Biol Rev Camb Philos Soc. 1995;70:571-596.
5. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med. 1995;1:74-79.
6. Metcalfe JC, Grainger DJ. Transforming growth factor-β and the protection from cardiovascular injury hypothesis. Biochem Soc Trans. 1995;23:403-406.
7. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein (a) mice. Nature. 1994;370:460-462.
8. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of TGF-β signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003;112:1342-1350.
9. Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K. Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease. Coron Artery Dis. 2002;13:139-143.
10. Saltis J, Agrotis A, Bobik A. Regulation and interactions of transforming growth factor-β with cardiovascular cells: implications for development and disease. Clin Exp Pharmacol Physiol. 1996;23:193-200.
11. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest. 1992;90:1582-1592.
12. Ohji T, Urano H, Shirahata A, Yamagishi M, Higashi K, Gotoh S, Karasaki Y. Transforming growth factor-β1 and -β2 induce downmodulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost. 1995;73:812-818.
13. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
14. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA. Overexpression of transforming growth factor-β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A. 1998;95:6983-6988.
15. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, Morisaki N. In vivo effect of TGF-β1: enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol. 1995;15:1951-1957.
16. Wang XL, Liu SX, Wilcken DE. Circulating transforming growth factor-β1 and coronary artery disease. Cardiovasc Res. 1997;34:404-410.
17. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure: the Etude Cas-Temoin de L'infarctus du Myocarde (ECTIM) Study. Hypertension. 1996;28:881- 887.
18. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin Sci (Lond). 1998;95:659-667.
19. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet. 1999;8:93-97.
20. Rao M, Guo D, Jaber BL, Tighiouart H, Pereira BJ, Balakrishnan VS. Transforming growth factor-β1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int. 2004;66:419-427.
21. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a t29→c polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101:2783-2787.
22. Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, Weimar W. The transforming growth factor-β1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. 2001;71:1463-1467.
23. Wang XL, Sim AS, Wilcken DE. A common polymorphism of the transforming growth factor-β1 gene and coronary artery disease. Clin Sci (Lond). 1998;95:745-746.
24. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-422.
25. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432-1437.
26. van Bemmel JH, Kors JA, van Herpen G. Methodology of the modular ECG analysis system means. Methods Inf Med. 1990;29:346-353.
27. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization; 1992.
28. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC. Interleukin 6 -174 G/C promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol. 2006;26:212-217.
29. Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, Mezzetti A, Porreca E. Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004;35:2253-2257.